You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Risk-Adapted Management of Multiple Myeloma in the Era of Modern Therapy

  • Authors: Joseph Mikhael, MD, MED, FRCPC; Sandra Kurtin, PhD, ANP-C, AOCN, FAPO; Kathryn Maples, PharmD, BCOP
  • CME / ABIM MOC / CE Released: 1/27/2023
  • Valid for credit through: 1/27/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    Pharmacists - 0.50 ACPE Contact Hour(s) (0.050 CEUs)

    IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for community-based hematologists/oncologists, nurses/nurse practitioners, and pharmacists.

The goal of this activity is for learners to be better able to identify, mitigate, and manage risks and adverse events associated with novel myeloma therapies.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Safety profiles of agents recently introduced for the treatment of multiple myeloma (MM)
  • Have greater competence related to
    • Implementing strategies for mitigating adverse events (AEs) associated with myeloma therapy
  • Demonstrate greater confidence in their ability to
    • Work as part of an interdisciplinary team to counsel and monitor patients being treated for MM regarding potential AEs


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


  • Joseph Mikhael, MD, MED, FRCPC

    Applied Cancer Research and Drug Discovery 
    Translational Genomics Research Institute (TGen)  
    City of Hope Cancer Center 
    Chief Medical Officer 
    International Myeloma Foundation 
    Phoenix, Arizona


    Joseph Mikhael, MD, MED, FRCPC, has the following relevant financial relationships:
    Consultant or advisor for: Amgen, Inc.; Bristol Myers Squibb Company; GlaxoSmithKline; Janssen; Karyopharm; Sanofi; Takeda
    Research funding from: Bristol Myers Squibb Company


  • Sandra Kurtin, PhD, ANP-C, AOCN, FAPO

    Assistant Professor of Clinical Medicine
    Assistant Professor of Nursing
    Advanced Practice
    The University of Arizona Cancer Center
    Tucson, Arizona


    Sandra Kurtin, PhD, ANP-C, AOCN FAPO, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Bristol Myers Squibb Company; Epizyme, Inc.; Incyte Corporation; Pharmacyclics, Inc.; Takeda

  • Kathryn Maples, PharmD, BCOP

    Clinical Pharmacy Specialist in Multiple Myeloma
    Winship Cancer Institute of Emory University
    Atlanta, Georgia


    Kathryn Maples, PharmD, BCOP, has the following relevant financial relationships:
    Consultant or advisor for: GlaxoSmithKline (former); Janssen (former); Karyopharm (former); Sanofi (former)


  • Megan Whitney, DMD

    Medical Education Director, 
    Medscape, LLC 


    Megan Whitney, DMD, has no relevant financial relationships.  

Compliance Reviewer/Nurse Planner

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-23-024-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Risk-Adapted Management of Multiple Myeloma in the Era of Modern Therapy

Authors: Joseph Mikhael, MD, MED, FRCPC; Sandra Kurtin, PhD, ANP-C, AOCN, FAPO; Kathryn Maples, PharmD, BCOPFaculty and Disclosures

CME / ABIM MOC / CE Released: 1/27/2023

Valid for credit through: 1/27/2024


A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print